Sign in
  • USA
  • UK
  • Germany
  • France
  • Canada
  • India
  • Italy
Sign in
Welcome!Log into your account
Forgot your password?
Password recovery
Recover your password
Search
LogoFinSMEs The Website About Venture Capital News
LogoFinSMEs The Website About Venture Capital News
  • USA
  • UK
  • Germany
  • France
  • Canada
  • India
  • Italy
Home Tags Boxer Capital

Tag: Boxer Capital

cancer
USA

Tyra Biosciences Raises USD 50M in Series A Funding

FinSMEs -
January 13, 2020
0
cancer
USA

Black Diamond Therapeutics Raises $85M in Series C Financing

FinSMEs -
December 5, 2019
0
cancer
USA

Nuvation Bio Raises $275M in Series A Financing

FinSMEs -
October 28, 2019
0
Zachary Hornby is President, Chief Executive Officer, and a Director of Boundless Bio
USA

Boundless Bio Raises $46M in Series A Funding

FinSMEs -
September 20, 2019
0
REVOLUTION Medicines
USA

Revolution Medicines Closes $100M Financing

FinSMEs -
July 9, 2019
0
poseida
USA

Poseida Therapeutics Closes $142M Series C Financing

FinSMEs -
April 22, 2019
0
SpringWorks Therapeutics
USA

SpringWorks Therapeutics Completes $125M Series B Financing

FinSMEs -
April 1, 2019
0
healthcare
USA

Prevail Therapeutics Secures $50M in Series B Financing

FinSMEs -
March 28, 2019
0
attune
USA

Attune Pharmaceuticals Closed $23M Series B Financing

FinSMEs -
January 24, 2019
0
Cabaletta Bio
USA

Cabaletta Bio Closes $50M Series B Financing

FinSMEs -
January 9, 2019
0
Sojournix
USA

Sojournix Completes $44M Series C Financing

FinSMEs -
January 3, 2019
0
Akero-Logo
USA

Akero Therapeutics Raises $70M in Financing

FinSMEs -
December 13, 2018
0
healthcare
Canada

Milestone Pharmaceuticals Raises $80M in Equity Funding

FinSMEs -
October 25, 2018
0
healthcare
USA

Atreca Raises $125M in Series C Funding

FinSMEs -
September 16, 2018
0
Ideaya Biosciences Raises $94M Crossover Series B Financing
USA

Ideaya Biosciences Raises $94M Crossover Series B Financing

FinSMEs -
March 15, 2018
0
1234Page 3 of 4
  • Contact
  • About
  • Privacy Policy
  • Advertise with Us
  • Disclaimer
  • GDPR
  • Terms & Conditions

Follow Us

Twitter